No
| Variant Name | Allele Count | Allele Frequency | Associated Disease | Associated Gene |
|---|---|---|---|---|
| NM_001311311.1:c.-1639G>A | 106 |
| Subject Id | Country | HPO Terms | Sex | Family History | Parental Consanguinity | Remarks |
|---|---|---|---|---|---|---|
| 122700.G.2.2 | Lebanon | 68 out of 231 total subjects. 13 homozygous subjects were used to determine the effects of variants on Warfarin and Acenocoumarol dosage, which was significantly lower than GA and GG carriers. | ||||
| 122700.G.2.3 | Lebanon | 52 out of 231 total subjects | ||||
| 122700.G.2.4 | Lebanon | 23 out of 231 total subjects. Allele carriers of this variant had a significantly lower dosage of warfarin compared to wild type. | ||||
| 122700.G.2.5 | Lebanon | 5 out of 231 total subjects | ||||
| 122700.G.2.6 | Lebanon | 9 out of 231 total subjects Allele carriers of the c.1075A>C variant had a significantly lower dosage of warfarin compared to wild type. |